orexin 2 receptor antagonists (Johnson and Johnson)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameorexin 2 receptor antagonists (Johnson and Johnson)
Drug Alias NameJNJ-10397049
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 antagonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A